Conference Proceedings

Are stable MS patients who stop their disease-modifying therapy (DMT) at increased risk for relapses and disability progression compared to patients who continue on DMTs? A propensity-score matched analysis of the MSBase registrants

I Kister, T Spelman, R Alroughani, J Lechner-Scott, P Duquette, F Grand'maison, M Slee, A Lugaresi, M Barnett, P Grammond, G Iuliano, R Hupperts, M Trojano, H Butzkueven

MULTIPLE SCLEROSIS JOURNAL | SAGE PUBLICATIONS LTD | Published : 2015